Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CSAD antisense RNA 1 (CSAD-AS1)
- Target
- CSAD-AS1
- Molecular classification
- Long non-coding RNA (lncRNA), Antisense RNA
01
Overview
CSAD antisense RNA 1, abbreviated as CSAD-AS1, is presumed to be a long non-coding RNA transcribed in the antisense orientation relative to the sense CSAD gene, which encodes cysteine sulfinic acid decarboxylase. While antisense lncRNAs in general can regulate gene expression by interacting with sense gene transcripts, chromatin, or epigenetic modifiers, there is currently no published biochemical, genomic, or clinical evidence specifically characterizing CSAD-AS1 as a distinct molecule, nor as a therapeutic target or biomarker.
02
Mechanism of action
Antisense lncRNAs may modulate gene expression by RNA-RNA interaction, chromatin modification, or transcriptional interference.
03
Biological functions
Regulation of gene expressionChromatin remodeling (general for antisense lncRNAs)Epigenetic regulation (general for antisense lncRNAs)
04
Disease associations
Other (no disease association reported specifically for CSAD-AS1; general antisense lncRNAs may be involved in cancer, immune response, or developmental diseases)
05
Safety considerations
No therapeutic use or safety information is available.
Beyond the preview
Go deeper on CSAD antisense RNA 1 (CSAD-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CSAD antisense RNA 1 (CSAD-AS1).